Labrador, Aldrin L.

HRN: 04-15-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2026
CEFUROXIME 750MG (VIAL)
03/22/2026
03/28/2026
IV
750mg
Q8
ATP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: